6-161034340-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005922.4(MAP3K4):āc.234G>Cā(p.Glu78Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K4 | NM_005922.4 | c.234G>C | p.Glu78Asp | missense_variant | 2/27 | ENST00000392142.9 | NP_005913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K4 | ENST00000392142.9 | c.234G>C | p.Glu78Asp | missense_variant | 2/27 | 1 | NM_005922.4 | ENSP00000375986.4 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251284Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135806
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461696Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727162
GnomAD4 genome AF: 0.000210 AC: 32AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.234G>C (p.E78D) alteration is located in exon 2 (coding exon 2) of the MAP3K4 gene. This alteration results from a G to C substitution at nucleotide position 234, causing the glutamic acid (E) at amino acid position 78 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at